The development of cancer immunotherapy for Immune checkpoint inhibitors (ICI) resistant cancers has been a challenge. Current ICI-based combination therapy strategies have achieved some, albeit

Drug development for Rare cancers is challenging because it is difficult to obtain relevant data from very few patients. The oncology community is increasingly facing

Breast Cancer Overview Introduction Breast cancer is a disease wherein cells in the breast grow out of control. Like all other cancers, breast cancer is